Somatostatin Market Drivers: Growing Prevalence of Neuroendocrine...

added blog Other

2026-06-11 15:22:14 -

Somatostatin Market Drivers: Growing Prevalence of Neuroendocrine Tumors and Endocrine Disorders Worldwide

Somatostatin Market Overview The global somatostatin market is witnessing substantial growth due to increasing demand for effective treatments targeting hormone-related disorders and neuroendocrine tumors. According to The Insight Partners, the global somatostatin market size is projected to reach US$ 1,096.69 million by 2034, rising from US$ 431.86 million in 2025, registering a robust...

0 Comments 0 Shares 60 Views 0 Reviews